PMID- 25870930 OWN - NLM STAT- MEDLINE DCOM- 20151130 LR - 20181113 IS - 1756-0500 (Electronic) IS - 1756-0500 (Linking) VI - 8 DP - 2015 Mar 7 TI - Four core genotypes mouse model: localization of the Sry transgene and bioassay for testicular hormone levels. PG - 69 LID - 10.1186/s13104-015-0986-2 [doi] LID - 69 AB - BACKGROUND: The "four core genotypes" (FCG) mouse model has emerged as a major model testing if sex differences in phenotypes are caused by sex chromosome complement (XX vs. XY) or gonadal hormones or both. The model involves deletion of the testis-determining gene Sry from the Y chromosome and insertion of an Sry transgene onto an autosome. It produces XX and XY mice with testes, and XX and XY mice with ovaries, so that XX and XY mice with the same type of gonad can be compared to assess phenotypic effects of sex chromosome complement in cells and tissues. FINDINGS: We used PCR to amplify the Sry transgene and adjacent genomic sequences, to resolve the location of the Sry transgene to chromosome 3 and confirmed this location by fluorescence in situ hybridization (FISH) of the Sry construct to metaphase chromosomes. Using quantitative PCR, we estimate that 12-14 copies of the transgene were inserted. The anogenital distance (AGD) of FCG pups at 27-29 days after birth was not different in XX vs. XY males, or XX vs. XY females, suggesting that differences between XX and XY mice with the same type of gonad are not caused by difference in prenatal androgen levels. CONCLUSION: The Sry transgene in FCG mice is present in multiple copies at one locus on chromosome 3, which does not interrupt known genes. XX and XY mice with the same type of gonad do not show evidence of different androgen levels prenatally. FAU - Itoh, Yuichiro AU - Itoh Y FAU - Mackie, Ryan AU - Mackie R FAU - Kampf, Kathy AU - Kampf K FAU - Domadia, Shelly AU - Domadia S FAU - Brown, Judith D AU - Brown JD FAU - O'Neill, Rachel AU - O'Neill R FAU - Arnold, Arthur P AU - Arnold AP LA - eng GR - R01 NS043196/NS/NINDS NIH HHS/United States GR - R01 HD076125/HD/NICHD NIH HHS/United States GR - DK083561/DK/NIDDK NIH HHS/United States GR - NS043196/NS/NINDS NIH HHS/United States GR - R01 DK083561/DK/NIDDK NIH HHS/United States GR - HD076125/HD/NICHD NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20150307 PL - England TA - BMC Res Notes JT - BMC research notes JID - 101462768 RN - 0 (Androgens) SB - IM MH - Androgens/genetics/*metabolism MH - Animals MH - *Biological Assay MH - Female MH - Gene Dosage MH - *Genes, sry MH - Genotype MH - In Situ Hybridization, Fluorescence MH - Male MH - Mice MH - Mice, Transgenic MH - Ovary/growth & development/metabolism MH - Phenotype MH - *Sex Characteristics MH - Testis/growth & development/metabolism MH - Transgenes MH - X Chromosome/*chemistry MH - Y Chromosome/*chemistry PMC - PMC4354741 EDAT- 2015/04/15 06:00 MHDA- 2015/12/15 06:00 PMCR- 2015/03/07 CRDT- 2015/04/15 06:00 PHST- 2014/10/24 00:00 [received] PHST- 2015/01/20 00:00 [accepted] PHST- 2015/04/15 06:00 [entrez] PHST- 2015/04/15 06:00 [pubmed] PHST- 2015/12/15 06:00 [medline] PHST- 2015/03/07 00:00 [pmc-release] AID - s13104-015-0986-2 [pii] AID - 986 [pii] AID - 10.1186/s13104-015-0986-2 [doi] PST - epublish SO - BMC Res Notes. 2015 Mar 7;8:69. doi: 10.1186/s13104-015-0986-2.